Perfusion-Based Selection for Endovascular Reperfusion Therapy in Anterior Circulation Acute Ischemic Stroke

References

1. 1.↵
   1. Furlan A,
   2. Higashida R,
   3. Wechsler L,
   4. et al

   . Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Ogawa A,
   2. Mori E,
   3. Minematsu K,
   4. et al

   . Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007;38:2633–39

   Abstract/FREE Full Text
3. 3.↵
   1. Smith WS,
   2. Sung G,
   3. Starkman S,
   4. et al

   . Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38

   Abstract/FREE Full Text
4. 4.↵
   Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761–68

   Abstract/FREE Full Text
5. 5.↵
   1. Fargen KM,
   2. Chaudry I,
   3. Turner RD,
   4. et al

   . A novel clinical and imaging based score for predicting outcome prior to endovascular treatment of acute ischemic stroke. J Neurointerv Surg 2013;5(suppl 1):i38–43

   Abstract/FREE Full Text
6. 6.↵
   1. Flint AC,
   2. Cullen SP,
   3. Faigeles BS,
   4. et al

   . Predicting long-term outcome after endovascular stroke treatment: the Totaled Health Risks in Vascular Events score. AJNR Am J Neuroradiol 2010;31:1192–96

   Abstract/FREE Full Text
7. 7.↵
   1. Hallevi H,
   2. Barreto AD,
   3. Liebeskind DS,
   4. et al

   . Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2009;40:1780–85

   Abstract/FREE Full Text
8. 8.↵
   1. Vora NA,
   2. Shook SJ,
   3. Schumacher HC,
   4. et al

   . A 5-item scale to predict stroke outcome after cortical middle cerebral artery territory infarction: validation from results of the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke 2011;42:645–49

   Abstract/FREE Full Text
9. 9.↵
   1. Yoo AJ,
   2. Verduzco LA,
   3. Schaefer PW,
   4. et al

   . MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009;40:2046–54

   Abstract/FREE Full Text
10. 10.↵
    1. Khatri P,
    2. Abruzzo T,
    3. Yeatts SD,
    4. et al

    . Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066–72

    CrossRef
11. 11.↵
    1. Hill MD,
    2. Rowley HA,
    3. Adler F,
    4. et al

    . Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003;34:1925–31

    Abstract/FREE Full Text
12. 12.↵
    1. Sheth KN,
    2. Terry JB,
    3. Nogueira RG,
    4. et al

    . Advanced modality imaging evaluation in acute ischemic stroke may lead to delayed endovascular reperfusion therapy without improvement in clinical outcomes. J Neurointerv Surg 2013;5(suppl 1):i62–65

    Abstract/FREE Full Text
13. 13.↵
    1. Hassan AE,
    2. Zacharatos H,
    3. Rodriguez GJ,
    4. et al

    . A comparison of computed tomography perfusion-guided and time-guided endovascular treatments for patients with acute ischemic stroke. Stroke 2010;41:1673–78

    Abstract/FREE Full Text
14. 14.↵
    1. Higashida RT,
    2. Furlan AJ,
    3. Roberts H,
    4. et al

    . Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–137

    Abstract/FREE Full Text
15. 15.↵
    1. Hacke W,
    2. Kaste M,
    3. Bluhmki E,
    4. et al

    . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–29

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Lansberg MG,
    2. Straka M,
    3. Kemp S,
    4. et al

    . MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012;11:860–67

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Sims JR,
    2. Gharai LR,
    3. Schaefer PW,
    4. et al

    . ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009;72:2104–10

    CrossRef
18. 18.↵
    1. Nogueira RG,
    2. Lutsep HL,
    3. Gupta R,
    4. et al

    . Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380:1231–40

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Saver JL,
    2. Jahan R,
    3. Levy EI,
    4. et al

    . Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241–49

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Rai AT,
    2. Raghuram K,
    3. Domico J,
    4. et al

    . Pre-intervention triage incorporating perfusion imaging improves outcomes in patients undergoing endovascular stroke therapy: a comparison with the device trials. J Neurointerv Surg 2013;5:121–27

    Abstract/FREE Full Text
21. 21.↵
    1. Abou-Chebl A

    . Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 2010;41:1996–2000

    Abstract/FREE Full Text
22. 22.↵
    1. Jovin TG,
    2. Liebeskind DS,
    3. Gupta R,
    4. et al

    . Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke 2011;42:2206–11

    Abstract/FREE Full Text
23. 23.↵
    1. Goyal M,
    2. Menon BK,
    3. Derdeyn CP

    . Perfusion imaging in acute ischemic stroke: let us improve the science before changing clinical practice. Radiology 2013;266:16–21

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Furlan AJ,
    2. Eyding D,
    3. Albers GW,
    4. et al

    . Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227–31

    Abstract/FREE Full Text
25. 25.↵
    1. Hacke W,
    2. Albers G,
    3. Al-Rawi Y,
    4. et al

    . The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73

    Abstract/FREE Full Text
26. 26.↵
    1. Hacke W,
    2. Furlan AJ,
    3. Al-Rawi Y,
    4. et al

    . Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141–50

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Warach S,
    2. Al-Rawi Y,
    3. Furlan AJ,
    4. et al

    . Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials. Stroke 2012;43:2313–18

    Abstract/FREE Full Text
28. 28.↵
    1. Albers GW,
    2. Thijs VN,
    3. Wechsler L,
    4. et al

    . Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508–17

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Davis SM,
    2. Donnan GA,
    3. Parsons MW,
    4. et al

    . Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Kidwell CS,
    2. Jahan R,
    3. Gornbein J,
    4. et al

    . A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368:914–23

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Bang OY,
    2. Saver JL,
    3. Kim SJ,
    4. et al

    . Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke 2011;42:693–99

    Abstract/FREE Full Text
32. 32.↵
    1. Bang OY,
    2. Saver JL,
    3. Kim SJ,
    4. et al

    . Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke 2011;42:2235–39

    Abstract/FREE Full Text
33. 33.↵
    1. Ostrem JL,
    2. Saver JL,
    3. Alger JR,
    4. et al

    . Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 2004;35:e30–04

    Abstract/FREE Full Text
34. 34.↵
    1. Gupta R,
    2. Horev A,
    3. Nguyen T,
    4. et al

    . Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes. J Neurointerv Surg 2013;5:294–97

    Abstract/FREE Full Text